ORP Services

Study Listing
Listserv
Informed Consent & HIPAA

Study Listing

Every three months, the ORP offers the service of listing active, Institutional Review Board (IRB) research studies currently recruiting on their website. Any investigator wishing to use the ORP website as a form of advertisement for recruiting should submit a Study Listing Form (RTF), located at the following URL: mib105@psu.edu. If you are not familiar with this service and would like to see a list of the current studies, please visit: http://www.research.psu.edu/orp/outreach/services/studylisting.asp. Only a total of 25 full review studies and 25 exemption/expedited studies can be posted on the ORP website at this time. Please note that Hershey Medical Center (HMC) investigators must go through the HMC IRB for approval to post their ad on the ORP website.

The ORP will accept study listings on a first-come, first-serve basis; however, the policy still stands that investigators who currently have studies listed are given the courtesy of renewing their listing first. Once your study is listed on the ORP website, you will have the option to continue having your study posted until you choose to remove it. A notice is sent approximately every three months and a response is required in order to continue with the ORP service of listing your research study.

If you are interested in adding your approved IRB study to the ORP website, please contact Michelle Panulla at 814-865-1775 or email the Study Listing Form (located at the above URL) to mib105@psu.edu. If you are not familiar with this service and would like to see a list of the current studies, please visit: http://www.research.psu.edu/orp/outreach/services/studylisting.asp.

ORP Listserv

The ORP recently developed a listserv, L-ORP-Research-L, to disseminate announcements on protocol deadlines, changes in protocol submissions, upcoming ORP events, office hours during the holidays, distribution of newsletters and other important research-related information. The listserv will be used sparingly and only to disseminate information that is important for all active researchers to know. Unlike most listservs, only the ORP has the ability to send notices to the listserv; thus, preventing any unnecessary information from being distributed.

Essential announcements will only be distributed to the ORP listserv and will no longer be sent out to all active Principal Investigators in the ORP database. Principal Investigators who were active until at least February 13, 2004 were added to the ORP listserv automatically. New Principal Investigators who became active after February 13, 2004 may not have been added to the listserv. If you did not receive the welcome message about being added to the listserv, it is possible that you were not added automatically. A notice has also been added to the application approval letters, providing information on how to subscribe and unsubscribe from the list.

The ORP encourages all Principal Investigators and Co-Investigators to subscribe to the ORP listserv. If you are interested in subscribing or being removed from ORP listserv, send an email to: L-ORP-Research-L-subscribe-request@lists.psu.edu to subscribe or L-ORP-Research-L-unsubscribe-request@lists.psu.edu to unsubscribe. There is no need to add any text in the subject line or in the message body of the email.

Informed Consent and HIPAA

Subjects must receive a copy of any informed consent documentation that was submitted to the Office for Research Protections for review. The principal investigator is expected to maintain the original signed consent forms along with the IRB research records for this research at least three (3) years after termination of IRB approval. For projects that involved protected health information (PHI) and are regulated by HIPAA, records are to be maintained for six (6) years. Additional requirements apply for FDA and sponsored trials, which the investigator should determine when applicable.